16-3 China approves recombinant subunit COVID vaccine

China approved a recombinant protein subunit vaccine against COVID-19 for emergency use. The vaccine was developed by the CAS Institute of Microbiology and Anhui Zhifei Longcom and is manufactured using CHO cells. It is the fourth vaccine approved in China for...

8-3 China will step-up basic research

According to the 14th Five-Year Plan and the 2035 Long-term Goal Outline Draft, China will formulate and implement a 10-year basic research action plan, focusing on developing Basic Research Centers and basic research expenses. The ratio will increase to 8% or more....